Related Experiment Videos
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD
D J Meecham Jones1, E A Paul, P W Jones
1Respiratory Care Unit, London Chest Hospital, United Kingdom.
American Journal of Respiratory and Critical Care Medicine
|August 1, 1995
Summary
Adding nasal positive pressure ventilation to long-term oxygen therapy significantly improves gas exchange and sleep quality in patients with chronic obstructive pulmonary disease (COPD). This combination therapy enhances daytime oxygen levels and reduces carbon dioxide, improving overall quality of life.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Non-invasive ventilation is used for chronic respiratory failure in COPD.
- The impact of adding nasal positive pressure ventilation (NPPV) to long-term oxygen therapy (LTOT) in stable hypercapnic COPD remains unclear.
Purpose of the Study:
- To evaluate the effect of combining nasal pressure support ventilation (NPSV) with domiciliary LTOT compared to LTOT alone in stable hypercapnic COPD patients.
Main Methods:
- A randomized crossover study involving 14 stable hypercapnic COPD patients.
- Patients underwent a 4-week run-in period followed by 3-month periods of LTOT alone and LTOT plus NPSV in randomized order.
- Assessments included daytime and overnight arterial blood gases, sleep parameters, and quality of life.
Main Results:
- Significant improvements observed in daytime PaO2 and PaCO2, total sleep time, and sleep efficiency with LTOT plus NPSV compared to LTOT alone.
- Quality of life was significantly better when NPSV was added to LTOT.
- Improvement in daytime PaCO2 correlated with improved overnight PaCO2.
Conclusions:
- Nasal positive pressure ventilation may be a beneficial addition to long-term oxygen therapy for patients with stable hypercapnic COPD.
- The combination therapy enhances respiratory function and patient well-being.